Five Prime Therapeutics Inc
METHODS OF TREATMENT WITH CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES
Last updated:
Abstract:
This application relates to use of CD80 (B7-1) extracellular domain (ECD) polypeptides and CD80-ECD fusion molecules and their use in methods of increasing the number of central memory T cells or for treatment for cancer or for use in cancer vaccine compositions.
Status:
Application
Type:
Utility
Filling date:
27 Apr 2018
Issue date:
11 Jun 2020